| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012246130 |
| P356 | DOI | 10.1007/S00125-003-1064-1 |
| P698 | PubMed publication ID | 12677400 |
| P5875 | ResearchGate publication ID | 10821251 |
| P2093 | author name string | M Giacca | |
| D Altavilla | |||
| F Squadrito | |||
| H Marini | |||
| B Deodato | |||
| D Cucinotta | |||
| M Galeano | |||
| V Torre | |||
| N Arsic | |||
| P2860 | cites work | Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways | Q45747525 |
| Novel tools for production and purification of recombinant adenoassociated virus vectors | Q45752072 | ||
| Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adenoassociated virus vector | Q45767412 | ||
| Recombinant AAV vector encoding human VEGF165 enhances wound healing. | Q45886584 | ||
| Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice | Q54146199 | ||
| Growth factors in wound healing | Q57465217 | ||
| Angiogenesis in wound healing | Q67715056 | ||
| A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates | Q67993122 | ||
| Effects of experimental diabetes, uremia, and malnutrition on wound healing | Q69721405 | ||
| Wound healing effect of malotilate in rats | Q71345646 | ||
| Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model | Q71615454 | ||
| Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors | Q73348784 | ||
| Recent advances in wound healing | Q73465932 | ||
| Selective uptake and sustained expression of AAV vectors following subcutaneous delivery | Q73595870 | ||
| Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse | Q73609424 | ||
| Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation | Q73666640 | ||
| Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models | Q74353188 | ||
| Role of vascular endothelial growth factor in the regulation of angiogenesis | Q33723796 | ||
| Molecular and biological properties of vascular endothelial growth factor | Q33737216 | ||
| Immune responses to adenovirus and adeno-associated virus in humans. | Q33874473 | ||
| Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. | Q33931625 | ||
| New treatments in ulcer healing and wound infection | Q34072007 | ||
| Virus-mediated gene transfer for cutaneous gene therapy | Q34085726 | ||
| Nonviral skin gene therapy | Q34085729 | ||
| Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer | Q34156759 | ||
| Human keratinocytes are a major source of cutaneous platelet-derived growth factor | Q34170407 | ||
| Impediments to wound healing | Q34475832 | ||
| Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study | Q34747226 | ||
| Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart | Q35576360 | ||
| Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing | Q35765155 | ||
| PDGF and FGF stimulate wound healing in the genetically diabetic mouse | Q35811771 | ||
| A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells | Q35864616 | ||
| Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 | ||
| Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. | Q36167355 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing | Q36231924 | ||
| In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins | Q36354722 | ||
| Large induction of keratinocyte growth factor expression in the dermis during wound healing | Q37126541 | ||
| Cutaneous tissue repair: basic biologic considerations. I. | Q38156179 | ||
| Studies of wound healing in experimental diabetes mellitus | Q39137675 | ||
| Adeno-associated virus as a vector for liver-directed gene therapy. | Q39583470 | ||
| The future of recombinant growth factors in wound healing | Q40839382 | ||
| The role of growth factors in wound healing | Q41012270 | ||
| Epidermis: an attractive target tissue for gene therapy | Q41013053 | ||
| Diabetes-obesity syndromes in mice | Q41463282 | ||
| Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration | Q41665871 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse | Q42492042 | ||
| Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds | Q42756003 | ||
| Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds | Q42930072 | ||
| Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice | Q44678756 | ||
| P433 | issue | 4 | |
| P921 | main subject | endothelium | Q111140 |
| wound healing | Q1509074 | ||
| P304 | page(s) | 546-555 | |
| P577 | publication date | 2003-04-02 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse | |
| P478 | volume | 46 |
| Q50453767 | A hypoxic inducible factor-1 alpha hybrid enhances collateral development and reduces vascular leakage in diabetic rats. |
| Q33576200 | A potential wound-healing-promoting peptide from salamander skin |
| Q64059597 | A short peptide potentially promotes the healing of skin wound |
| Q42259507 | A slow-release fibrin matrix increases adeno-associated virus transduction of wound repair cells in vivo |
| Q36186814 | Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery |
| Q36673673 | Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing |
| Q47330704 | Apratyramide, a Marine-Derived Peptidic Stimulator of VEGF-A and Other Growth Factors with Potential Application in Wound Healing |
| Q46153058 | Assessment of wound healing in the alloxan-induced diabetic rabbit ear model |
| Q35094462 | Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. |
| Q40086141 | COMP-angiopoietin 1 Gene Transfer Enhances Cutaneous Wound Healing by Promoting Angiogenesis. |
| Q34596705 | COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model |
| Q34362253 | COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats. |
| Q28830781 | CRISPR-Cas9 directed knock-out of a constitutively expressed gene using lance array nanoinjection |
| Q26866424 | Clinical Impact Upon Wound Healing and Inflammation in Moist, Wet, and Dry Environments |
| Q34128496 | Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice |
| Q55042287 | Deficiency of liver-derived insulin-like growth factor-I (IGF-I) does not interfere with the skin wound healing rate. |
| Q99605423 | Design of an Interpenetrating Polymeric Network Hydrogel Made of Calcium-Alginate from a Thermos-Sensitive Pluronic Template as a Thermal-Ionic Reversible Wound Dressing |
| Q45871894 | Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis |
| Q46940901 | Effect of enamel matrix derivative protein on the healing of standardized epithelial wounds: a histomorphometric analysis in vivo |
| Q43251758 | Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes |
| Q44770946 | Effects of a topical enamel matrix derivative on skin wound healing |
| Q44807643 | Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial. |
| Q33829920 | Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques |
| Q45877414 | Fibrin scaffold promotes adenoviral gene transfer and controlled vector delivery |
| Q41294009 | From Inflammation to Current and Alternative Therapies Involved in Wound Healing |
| Q26994703 | Gene therapy for skin diseases |
| Q45883172 | Gene therapy in the treatment of lower extremity wounds |
| Q37322691 | HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells |
| Q33460409 | Heme oxygenase-1 accelerates cutaneous wound healing in mice |
| Q53556565 | Impaired integration of endothelial progenitor cells in capillaries of diabetic wounds is reversible with vascular endothelial growth factor infusion. |
| Q45871657 | Influence of needle gauge on in vivo ultrasound and microbubble-mediated gene transfection. |
| Q37719403 | Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice. |
| Q39290989 | Innovations in Gene and Growth Factor delivery systems for Diabetic Wound Healing |
| Q38413562 | Juglone ameliorates skin wound healing by promoting skin cell migration through Rac1/Cdc42/PAK pathway |
| Q39995501 | Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. |
| Q35033659 | MicroRNAs in skin and wound healing. |
| Q47155596 | Naringin improves random skin flap survival in rats |
| Q79796020 | Nitric oxide accelerates the recovery from burn wounds |
| Q92734088 | Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms |
| Q37952338 | Potential role of statins on wound healing: review of the literature. |
| Q40716965 | Pseudotyped adeno-associated viral vector tropism and transduction efficiencies in murine wound healing |
| Q42580337 | Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications. |
| Q33605750 | Regulation of scar formation by vascular endothelial growth factor |
| Q37532442 | Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice |
| Q37039583 | Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice |
| Q49292081 | Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice |
| Q46468770 | The role of vascular endothelial growth factor in wound healing |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q39677727 | Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing |
| Q40597108 | Topical fentanyl stimulates healing of ischemic wounds in diabetic rats |
| Q40701859 | Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions. |
| Q40508894 | Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats |
| Q53818786 | Treatment of limb wounds of horses with orf virus IL-10 and VEGF-E accelerates resolution of exuberant granulation tissue, but does not prevent its development. |
| Q64087177 | Use of Biologically Active 3D Matrix for Extensive Skin Defect Treatment in Veterinary Practice: Case Report |
| Q47632950 | Use of Promogran to treat venous leg ulcers |
| Q34486906 | Use of natural neural scaffolds consisting of engineered vascular endothelial growth factor immobilized on ordered collagen fibers filled in a collagen tube for peripheral nerve regeneration in rats |
| Q58806294 | VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury |
| Q27023354 | Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair |
| Q46670896 | Vascular endothelial growth factor promotes macrophage apoptosis through stimulation of tumor necrosis factor superfamily member 14 (TNFSF14/LIGHT). |
Search more.